Differences in tolerability of pirfenidone between elderly and younger patients with idiopathic pulmonary fibrosis

PURPOSE: Although pirfenidone (PFD) is a key drug for the treatment of idiopathic pulmonary fibrosis (IPF), differences in tolerability between elderly and young patients remain unclear. This study aimed to investigate age-related differences in adverse drug reactions to PFD and to evaluate whether...

詳細記述

保存先:
書誌詳細
出版年:Drug Des Devel Ther
主要な著者: Sakayori, Masashi, Terada, Jiro, Abe, Mitsuhiro, Hirasawa, Yasutaka, Suzuki, Kenichi, Yoshioka, Keiichiro, Tsushima, Kenji, Tatsumi, Koichiro
フォーマット: Artigo
言語:Inglês
出版事項: Dove 2019
主題:
Original Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6630358/
https://ncbi.nlm.nih.gov/pubmed/31371923
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S208733
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料